Jeffrey M. Rosen

Baylor College of Medicine — United States

Medicine · Health Sciences

92h-index33.5kcitations623works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(170), Animal Genetics and Reproduction(90), Cancer-related Molecular Pathways(79), Fibroblast Growth Factor Research(64), RNA modifications and cancer(52)

Publications618 total

Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers
Nature Communications·2026Open Access
The legacy and future of recurrent neural networks in personalized medicine: A reflection on the 2024 Nobel Physics Prize
Biomedical Journal·2025· 1 citedOpen Access
FGFR1-Activated Translation of WNT Pathway Components with Structured 5′ UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation
UNC Libraries·2025Open Access
Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 TherapeuticsPLK2 as a Biomarker for PLK1 Therapeutics
UNC Libraries·2025Open Access
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer
UNC Libraries·2025Open Access
Supplementary Table 1 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure Legend from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 6 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 3 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 4 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 5 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 1 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Data from LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells
2025Open Access
Supplementary Figure 7 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Supplementary Figure 2 from Targeted Inhibition of lncRNA <i>Malat1</i> Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
2025Open Access
Abstract P2-06-01: CBP/P300 bromodomain inhibition reduces neutrophil accumulation and activates antitumor immunity in TNBC
Clinical Cancer Research·2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers
2025· 1 citedOpen Access
Abstract 7126: Divergent molecular features associated with immune checkpoint blockade response
Cancer Research·2025
Histone acetylation modulators in breast cancer
Breast Cancer Research·2025· 5 citedOpen Access
Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway
Cell Reports Medicine·2025· 9 citedOpen Access
page 1 of 31Next →

Frequent Co-authors

Jason I. Herschkowitz(7), Fariba Behbod(6), Michael T. Lewis(5), Thomas F. Westbrook(5), Xiang H.-F. Zhang(5), Jenny C. Chang(4), Susan G. Hilsenbeck(4), Sendurai A. Mani(4), Wendy A. Woodward(4), Mei Zhang(4), Charles M. Perou(3), Francesco J. DeMayo(3), Milton J. Finegold(3), Robert J. Matusik(3), Joseph H. Taube(3), Mercy S. Chen(3), Yi Li(3), Thomas Welte(3), Rachel L. Atkinson(3), David G. Edwards(3)